Recent Hints on the Dual Role of Discs Large MAGUK Scaffold Protein 5 in Cancers and in Hepatocellular Carcinoma.

IF 3.1 4区 生物学 Q2 Immunology and Microbiology Frontiers in Bioscience-Landmark Pub Date : 2022-05-20 DOI:10.31083/j.fbl2705164
Chiara Andolfi, C. Tiribelli, D. Pascut
{"title":"Recent Hints on the Dual Role of Discs Large MAGUK Scaffold Protein 5 in Cancers and in Hepatocellular Carcinoma.","authors":"Chiara Andolfi, C. Tiribelli, D. Pascut","doi":"10.31083/j.fbl2705164","DOIUrl":null,"url":null,"abstract":"Discs large MAGUK scaffold protein 5 (DLG5) is a multi-domain member of membrane-associated guanylate kinase (MAGUK) family, which plays a major role in the maintenance of cell epithelial polarity being part of the SCRIB-LGL-DLG complex. Although polarity proteins have been generally considered tumor suppressors, recent discoveries led to reconsidering their role in cancer. This is also true for DLG5 in different cancer types, including hepatocellular carcinoma (HCC). In this cancer, DLG5 was negatively associated with malignant characteristics, however recent findings associated DLG5 expression with advanced stages of HCC. In vitro studies evidenced its possible role in sustaining cell growth and migration by the interaction with several intracellular pathways, such as Hippo, Hedgehog, and PI3K/AKT signaling pathways. In this review, we summarize the recent finding on the dual role of DLG5 and other polarity proteins in cancers. What emerges is a still undefined role of those proteins in cancers, especially in HCC, one of the most frequent cancers worldwide, where the function of DLG5 and other polarity proteins is still largely unexplored.","PeriodicalId":50430,"journal":{"name":"Frontiers in Bioscience-Landmark","volume":"114 1","pages":"164"},"PeriodicalIF":3.1000,"publicationDate":"2022-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioscience-Landmark","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.31083/j.fbl2705164","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Immunology and Microbiology","Score":null,"Total":0}
引用次数: 2

Abstract

Discs large MAGUK scaffold protein 5 (DLG5) is a multi-domain member of membrane-associated guanylate kinase (MAGUK) family, which plays a major role in the maintenance of cell epithelial polarity being part of the SCRIB-LGL-DLG complex. Although polarity proteins have been generally considered tumor suppressors, recent discoveries led to reconsidering their role in cancer. This is also true for DLG5 in different cancer types, including hepatocellular carcinoma (HCC). In this cancer, DLG5 was negatively associated with malignant characteristics, however recent findings associated DLG5 expression with advanced stages of HCC. In vitro studies evidenced its possible role in sustaining cell growth and migration by the interaction with several intracellular pathways, such as Hippo, Hedgehog, and PI3K/AKT signaling pathways. In this review, we summarize the recent finding on the dual role of DLG5 and other polarity proteins in cancers. What emerges is a still undefined role of those proteins in cancers, especially in HCC, one of the most frequent cancers worldwide, where the function of DLG5 and other polarity proteins is still largely unexplored.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
椎间盘大MAGUK支架蛋白5在癌症和肝细胞癌中的双重作用的最新提示。
盘状大MAGUK支架蛋白5 (DLG5)是膜相关鸟苷酸激酶(MAGUK)家族的一个多结构域成员,作为SCRIB-LGL-DLG复合体的一部分,在维持细胞上皮极性方面起着重要作用。虽然极性蛋白通常被认为是肿瘤抑制因子,但最近的发现使人们重新考虑它们在癌症中的作用。DLG5在不同类型的癌症中也是如此,包括肝细胞癌(HCC)。在这种癌症中,DLG5与恶性特征呈负相关,然而最近的研究结果将DLG5的表达与晚期HCC联系起来。体外研究表明,它可能通过与Hippo、Hedgehog和PI3K/AKT信号通路等细胞内通路相互作用,维持细胞生长和迁移。本文就DLG5和其他极性蛋白在肿瘤中的双重作用的最新研究进展进行综述。这些蛋白在癌症中的作用仍不明确,尤其是在HCC中,DLG5和其他极性蛋白的功能在很大程度上仍未被探索。HCC是世界上最常见的癌症之一。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Frontiers in Bioscience-Landmark
Frontiers in Bioscience-Landmark 生物-生化与分子生物学
CiteScore
3.40
自引率
3.20%
发文量
301
审稿时长
3 months
期刊介绍: FBL is an international peer-reviewed open access journal of biological and medical science. FBL publishes state of the art advances in any discipline in the area of biology and medicine, including biochemistry and molecular biology, parasitology, virology, immunology, epidemiology, microbiology, entomology, botany, agronomy, as well as basic medicine, preventive medicine, bioinformatics and other related topics.
期刊最新文献
Bulimia Nervosa and Depression, from the Brain to the Gut Microbiota and Back Exosomal miR-423-5p Derived from Mineralized Osteoblasts Promotes Angiogenesis of Endothelial Cells by Targeting CXCL10 Role of Podocyte in Kidney Disease Exploring the Link between Metabolic Remodelling and Reactive Oxygen Species in the Aged and Diseased Heart Molecular Regulation of Bone Turnover in Juvenile Idiopathic Arthritis: Animal Models, Cellular Features and TNFα
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1